San Diego-primarily based Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug marketplace in February immediately after revealing promising info from the mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when provided being a weekly injection As